SpringWorks Therapeutics, Inc.
$5.3M 4,420 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
KLS-Martin L.P.
KLS-Martin L.P. reported $5,316,252.76 across General Payments, Research, and Ownership to 6,287 physicians and teaching hospitals across 6,287 transactions.
- $5.3M Top quartile payer
- All-tracks total
- 6,287 Top quartile volume
- Transactions
- 6,287 Top quartile reach
- Recipients
- +$1.2M
- General Payments vs PY2023
KLS-Martin L.P. reported $5,316,252.76 across all CMS Open Payments tracks (General + Research + Ownership) to 6,287 physicians and teaching hospitals in Program Year 2024 - ranking #263 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $5,316,252.76, averaging $845.59 per recipient.
KLS-Martin L.P.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
C
68/100
Total payments
D
59/100
Transaction volume
D
56/100
Physician reach
D
58/100
Payment type diversity
A
100/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer kls-martin-l-p KLS-Martin L.P.
$5.3M · #263/1,925 · 0.0% industry · PY2024
- TOT $5.3M
- RANK #263
- SHARE 0.0%
- TXN 6,287
- RCP 6,287
- CAT 11
- GEN $5.3M
- ΔGEN +$1.2M
- TOP1 10.4%
- PY 2024
Volume peers
Nearest volume peer: SpringWorks Therapeutics, Inc. ($5.3M)
KLS-Martin L.P. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
KLS-Martin L.P.'s CMS-reported General Payments increased by $1.2M (+28.3%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: KLS-MARTIN L.P.PY2023: KLS-MARTIN L.P.PY2024: KLS-Martin L.P.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $4,144,237.83
- PY2024
- $5,316,252.76
What the Data Shows for KLS-Martin L.P.
CMS Open Payments is not a single ledger: the all-tracks total shown above is General Payments plus Research Payments plus Ownership/Investment interests, each with its own disclosure rules. For KLS-Martin L.P. that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). Data for a given Program Year arrives roughly a year after the period it covers; our methodology page documents the release cadence and how we standardize the tracks for cross-company comparison.
"Long-Term Medical Supply or Device Loan" leads the 11-category general-payment breakdown below at $1.9M (36.6% of General Payments, 2,303 transactions) - see our methodology for how research and ownership payments are reported separately.
General Payment Breakdown by Type
"Long-Term Medical Supply or Device Loan" leads KLS-Martin L.P.'s 11-category general-payment breakdown at $1.9M, 36.6% of the reported total.
KLS-Martin L.P. reports 11 general-payment categories - the top three are Long-Term Medical Supply or Device Loan (36.6%), Royalty or License (18.8%), and Debt Forgiveness (18.8%). The remaining 8 categories make up 25.8% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
Category breadth matters here: KLS-Martin L.P. files across 11 named CMS general-payment types in Program Year 2024, versus manufacturers that report a single dominant category. The chart and table below enumerate every type with an amount above zero for this company.
How KLS-Martin L.P. divides its payments
Ranked by total dollars reported per category
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Long-Term Medical Supply or Device Loan | $1.9M | 2,303 | 36.6% |
| Royalty or License | $999.3K | 75 | 18.8% |
| Debt Forgiveness | $998.7K | 439 | 18.8% |
| Grant | $983.1K | 143 | 18.5% |
| Food and Beverage | $209.7K | 3,184 | 3.9% |
| Space Rental or Facility Fees | $82.5K | 20 | 1.6% |
| Honoraria | $42.3K | 25 | 0.8% |
| Travel and Lodging | $35.6K | 78 | 0.7% |
| Consulting Fee | $16.6K | 9 | 0.3% |
| Education | $891.00 | 9 | 0.0% |
| Entertainment | $32.60 | 2 | 0.0% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $1,763,557.05 (33.2%) of $5,316,252.76 in this company's General Payments records across 1,867 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for KLS-Martin L.P.
The five named recipients with the highest reported General Payments from this company
- 1
Georgetown University Hospital
$554,062.39 across 862 reported transactions
- 2
Hospital Of The Univ Of Penna
$401,084.78 across 99 reported transactions
- 3
Stony Brook University Hospital
$315,866.70 across 597 reported transactions
- 4
Lenox Hill Hospital
$283,949.76 across 103 reported transactions
- 5
David Notrica
$208,593.42 across 3 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
KLS-Martin L.P. ranks #263 of 1,925 by total payments (top 14% by spend) but spreads that money notably more broadly than its spend rank alone would suggest -- #1,436 of 1,838 by HHI (bottom 22% least concentrated), a wider distribution than most similarly sized payers.
View all 12 companies in this HHI neighborhood as a list
- Davol Inc. : $4.4M total payments, HHI 337
- Eli Lilly Export S.A. Puerto Rico Branch : $47.2K total payments, HHI 334
- Profound Medical Corp. : $125.2K total payments, HHI 329
- Argenx US, Inc. : $3.5M total payments, HHI 327
- DC Dental, LLC : $12.9K total payments, HHI 327
- Intra-Sana Laboratories : $291.3K total payments, HHI 327
- KLS-Martin L.P. (this company) : $5.3M total payments, HHI 326
- Evolution Surgical, Inc : $74.8K total payments, HHI 324
- Sanofi Pasteur Inc. : $1.9M total payments, HHI 323
- SomnoMed Inc. : $20.8K total payments, HHI 323
- Tolmar, Inc. : $420.1K total payments, HHI 322
- Ancora Heart, Inc. : $136.9K total payments, HHI 320
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as KLS-Martin L.P.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about KLS-Martin L.P..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with KLS-Martin L.P..
Showing 6 of 1,924 companies with CMS-reported payment data.
Pacira Pharmaceuticals Incorporated
$5.4M 18,305 recipients
Compare payment profiles
Olympus Corporation of the Americas
$5.2M 4,448 recipients
Compare payment profiles
Valencia Technologies Corporation
$5.4M 473 recipients
Compare payment profiles
Mitsubishi Tanabe Pharma America, Inc.
$5.2M 3,683 recipients
Compare payment profiles
BioXcel Therapeutics, Inc.
$5.2M 532 recipients
Compare payment profiles
Put this to use
KLS-Martin L.P. ranks #263 of 1,925 by all-tracks total payments, led by "Long-Term Medical Supply or Device Loan".
- See where KLS-Martin L.P. sits among every top spender on the full leaderboard. Top 100 by total payments
- Compare "Long-Term Medical Supply or Device Loan" spend across every manufacturer, not just KLS-Martin L.P.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.